These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 22722669

  • 1. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
    Lim TS, Hong YH, Lee HY, Choi JY, Kim HS, Moon SY.
    Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
    [Abstract] [Full Text] [Related]

  • 2. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.
    Shinno H, Inagaki T, Miyaoka T, Okazaki S, Kawamukai T, Utani E, Inami Y, Horiguchi J.
    J Neurol Sci; 2007 Sep 15; 260(1-2):132-8. PubMed ID: 17540407
    [Abstract] [Full Text] [Related]

  • 3. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr 15; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 4. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
    Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M.
    J Alzheimers Dis; 2011 Apr 15; 27(3):591-601. PubMed ID: 21841260
    [Abstract] [Full Text] [Related]

  • 5. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T, Xiao SF, Li X, Wang Y, Ding B, Ling HW, Chen KM.
    Zhonghua Yi Xue Za Zhi; 2009 Jan 06; 89(1):37-40. PubMed ID: 19489242
    [Abstract] [Full Text] [Related]

  • 6. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Jan 06; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
    Ding B, Chen KM, Ling HW, Zhang H, Chai WM, Li X, Wang T.
    Dement Geriatr Cogn Disord; 2008 Jan 06; 25(3):218-25. PubMed ID: 18219201
    [Abstract] [Full Text] [Related]

  • 9. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
    Tsai CF, Hung CW, Lirng JF, Wang SJ, Fuh JL.
    East Asian Arch Psychiatry; 2013 Sep 06; 23(3):86-90. PubMed ID: 24088401
    [Abstract] [Full Text] [Related]

  • 10. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME, Przybelski SA, Lesnick TG, Liesinger AM, Spychalla A, Zhang B, Gunter JL, Parisi JE, Boeve BF, Knopman DS, Petersen RC, Jack CR, Dickson DW, Kantarci K.
    J Neurosci; 2014 Dec 03; 34(49):16247-55. PubMed ID: 25471565
    [Abstract] [Full Text] [Related]

  • 11. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Rami L, Gómez-Ansón B, Bosch B, Sánchez-Valle R, Monte GC, Villar A, Molinuevo JL.
    Dement Geriatr Cogn Disord; 2007 Dec 03; 24(4):274-9. PubMed ID: 17717413
    [Abstract] [Full Text] [Related]

  • 12. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR, den Hollander JA, Stewart CC, Evanochko WT, Buchthal SD, Harrell LE, Zamrini EY, Brockington JC, Marson DC.
    NMR Biomed; 2007 Dec 03; 20(8):709-16. PubMed ID: 17295394
    [Abstract] [Full Text] [Related]

  • 13. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 03; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 14. Reduced N-acetylaspartate to creatine ratio in the posterior cingulate correlates with cognition in Alzheimer's disease following four months of rivastigmine treatment.
    Penner J, Wells JL, Borrie MJ, Woolmore-Goodwin SM, Bartha R.
    Dement Geriatr Cogn Disord; 2015 Dec 03; 39(1-2):68-80. PubMed ID: 25358336
    [Abstract] [Full Text] [Related]

  • 15. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y.
    Int Psychogeriatr; 2012 Jan 03; 24(1):19-27. PubMed ID: 21676281
    [Abstract] [Full Text] [Related]

  • 16. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 Jan 03; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

  • 17. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2013 Jan 03; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.